GeoVax Labs, Inc.

( )
GOVX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -0.40%282.621.5%$846.35m
MRNAModerna, Inc. -0.58%175.380.0%$764.29m
GILDGilead Sciences, Inc. -1.22%85.211.0%$712.21m
REGNRegeneron Pharmaceuticals, Inc. 0.71%741.482.6%$477.59m
VRTXVertex Pharmaceuticals, Inc. 0.74%315.301.9%$412.70m
BIIBBiogen, Inc. -4.34%291.901.8%$344.20m
ILMNIllumina, Inc. -0.95%216.913.2%$252.36m
SNSSSunesis Pharmaceuticals, Inc. -9.35%2.520.7%$176.16m
BNTXBioNTech SE 4.29%161.490.0%$168.04m
BMRNBioMarin Pharmaceutical, Inc. 1.80%98.664.2%$153.96m
AXSMAxsome Therapeutics, Inc. 31.54%74.741.6%$145.83m
MRTXMirati Therapeutics, Inc. -2.99%95.671.6%$134.05m
TECHBio-Techne Corp. -2.53%330.404.5%$124.21m
NVAXNovavax, Inc. 0.61%16.6475.3%$71.50m
HALOHalozyme Therapeutics, Inc. 3.29%56.4718.4%$70.68m

Company Profile

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of immunotherapies and vaccines against cancers and infectious diseases using a novel vector vaccine platform. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus (HIV), as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.